Global Navigation
Digitalk: Making pharma part of the conversation
Through a series of breakfast meetings, Digitalk will look at what pharma can learn from its consumer cousins and how the industry can engage with its audience more effectively through the multitude of digital media and communications tools available.
At the second Digitalk session, held in December, the RAPP team focused on social media. Topics covered included the challenges and the risks faced by pharma companies when engaging via social media and included information about the regulatory impacts on this medium. The session also included a series of useful case studies.
The videos below contain the highlights of the sessions.
Were you there? What did you think?
"The Digitalk event was very good, offered a good opportunity to ask questions of the panel, and a great opportunity to network with your peers."
Jill Jackling, MSI Projects Co-Ordinator, Servier Laboratories Limited
Send your comments for inclusion here to webeditor@pmlive.com
The first Digitalk session touched on some of the issues preventing pharma from diving in to digital, as well as looking at the importance of some key tactics such as search engine optimisation (SEO) and external link building. Full coverage and the videos from the session are available to watch online.
About Digitalk
Digitalk is an initiative designed to explore how leading edge digital marketing techniques can be used in the pharma market. Digitalk is produced by RAPP
You can become part of the conversation by joining the Digitalk group on LinkedIn or by registering for the next breakfast meeting
Published: 24/12/2010
Area: Pharmaceutical marketing and communications articlesArticle type: Healthcare Features
Healthcare Category: Healthcare advertising
Jobs & Careers
Latest content
| PRA expands its European operations with new UK and Dutch offices |
| Daiichi to research cancer drugs with Japan’s National Cancer Centre |